about
Identification of GATA6 sequence variants in patients with congenital heart defects.MicroRNA miR145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cellsPharmacological inhibitor of notch signaling stabilizes the progression of small abdominal aortic aneurysm in a mouse model.Dynamic Heterogeneity of the Heart Valve Interstitial Cell Population in Mitral Valve Health and DiseaseEndothelial Notch1 Is Required for Proper Development of the Semilunar Valves and Cardiac Outflow Tract.Genetic basis of aortic valvular disease.Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease.The evolving role of ankyrin-B in cardiovascular disease.Notch1 haploinsufficiency causes ascending aortic aneurysms in mice.Defining the molecular signatures of human right heart failure.Submicroscopic Chromosomal Copy Number Variations Identified in Children With Hypoplastic Left Heart SyndromeMG 53 Protein Protects Aortic Valve Interstitial Cells From Membrane Injury and Fibrocalcific RemodelingMechanisms and Alterations of Cardiac Ion Channels Leading to Disease: Role of Ankyrin-B in Cardiac FunctionProtein Phosphatase 2A Regulates Cardiac Na+ ChannelsβIV-Spectrin regulates STAT3 targeting to tune cardiac response to pressure overloadAnkyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapyDefining new mechanistic roles for αII spectrin in cardiac functionDevelopmental origins for semilunar valve stenosis identified in mice harboring congenital heart disease-associated GATA4 mutationFloppy Mitral Valve/Mitral Valve Prolapse (FMV/MVP): An unrevealed genotype - Phenotype relationshipPotential use of ivabradine for treatment of atrial fibrillation
P50
Q34134235-D9E560F9-A74C-4370-BAC9-79F9EC0D53ABQ34987622-260B2F30-82BB-4146-9EC4-9FBD2B4F9E9AQ35114888-0FABE3F4-588A-44DA-92A0-7F0A38BD6958Q36222898-6F0A1917-E278-48C9-8E65-A93CF983CBA0Q36831801-4121E4B8-ECED-4F41-8317-140F5EE6F886Q39117737-1EF1BA2E-388F-43F8-B577-5D69718CBAA8Q40748118-4C3D3FF3-8D46-43F9-9D4C-5F3E352459E8Q48002945-217F1DBB-4AFD-4ED3-825F-1A33F40A801EQ49262687-F4BF942A-29C6-47B7-8830-5597C88EE42BQ49794362-986C4B12-4261-44DF-B1D4-556E529FB7FDQ57828161-5DEAFF24-7504-4406-8B15-45CFADE0A6F6Q64241892-7A7E89C2-15DE-43E9-AF74-8D2ABF3BC164Q89551637-799D0EFF-7BF7-4D7D-90E5-226D31C89141Q90852065-0DFF6013-B357-46D5-B7BA-33D5D3CD4425Q91506269-43DA4BD2-196C-408B-AA61-4D8BBDB12F24Q91546271-DCD52575-8CEA-453D-87CF-384D905DEC95Q91832008-C40D3422-7549-40BF-A82F-BC4E9D5AB8E8Q92354322-8A2055B5-FD1B-4DD4-904E-7BD188CC76D4Q92691388-A0470EDC-64B0-4A71-B05C-B8708C0E6CC5Q93066690-7610AD6C-9BD0-4858-8A60-0A6CC2A88E31
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Sara N Koenig
@en
Sara N Koenig
@nl
type
label
Sara N Koenig
@en
Sara N Koenig
@nl
prefLabel
Sara N Koenig
@en
Sara N Koenig
@nl
P31
P496
0000-0002-5416-8621